{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:51:07Z","timestamp":1792813867074,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":704,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1\u2010TR001857"],"award-info":[{"award-number":["UL1\u2010TR001857"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1111\/jth.15141","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T05:13:41Z","timestamp":1603170821000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cangrelor PK\/PD analysis in post\u2010operative neonatal cardiac patients at risk for thrombosis"],"prefix":"10.1016","volume":"19","author":[{"given":"Diana","family":"Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanand","family":"Allada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganga","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schmidhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kreutzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Bacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Diacovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15141_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ppedcard.2005.09.003","article-title":"Thrombosis in children with BT shunts, glenns and fontans","volume":"21","author":"Monagle","year":"2005","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1111\/jth.15141_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0003-4975(03)00168-1","article-title":"Interim mortality in infants with systemic\u2010to pulmonary artery shunts","volume":"76","author":"Fenton","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.15141_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.athoracsur.2011.02.030","article-title":"Risk factors for mortality and morbidity after the neonatal Blalock\u2010Taussig shunt procedure","volume":"92","author":"Petrucci","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.15141_bb0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/1076029616679506","article-title":"Incidence and management of thrombotic and thromboembolic complications following the Norwood procedure: a systematic review","volume":"23","author":"Agarwal","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.15141_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jtcvs.2010.10.033","article-title":"Early systemic\u2010to\u2010pulmonary shunt intervention in neonates with congenital heart disease","volume":"142","author":"O\u2019Connor","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.15141_bb0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.athoracsur.2013.03.026","article-title":"In\u2010hospital shunt occlusion in infants undergoing a modified Blalock\u2010Taussig shunt","volume":"96","author":"Guzzetta","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.15141_bb0040","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jtcvs.2019.06.015","article-title":"High\u2010dose heparin is associated with higher bleeding and thrombosis rates in pediatric patients following cardiac surgery","volume":"158","author":"Vorisek","year":"2019","journal-title":"J Thorac and Cardiovasc Surg"},{"key":"10.1111\/jth.15141_bb0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jtcvs.2013.10.063","article-title":"Defining the best practice patterns for the neonatal systemic\u2010to\u2010pulmonary artery shunt procedure","volume":"147","author":"Heidari\u2010Bateni","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.15141_bb0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.106.652172","article-title":"Clinical outcomes of palliative surgery including a systemic\u2010to\u2010pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?","volume":"116","author":"Li","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/jth.15141_bb0055","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.athoracsur.2015.02.026","article-title":"Aspirin resistance in single\u2010ventricle physiology: aspirin prophylaxis is not adequate to inhibit platelets in the immediate postoperative period","volume":"99","author":"Mir","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.15141_bb0060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jtcvs.2014.06.016","article-title":"Aspirin unresponsiveness predicts thrombosis in high\u2010risk pediatric patients after cardiac surgery","volume":"148","author":"Emani","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.15141_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S1047951118002536","article-title":"High acetylsalicylic acid dosing in infants after modified Blalock\u2010Taussig shunt","volume":"29","author":"Saini","year":"2019","journal-title":"Cardiol Young"},{"key":"10.1111\/jth.15141_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FJC.0b013e31820d1c54","article-title":"Pediatric cardiovascular drug trials, lessons learned","volume":"58","author":"Li","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/jth.15141_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/pr.2016.221","article-title":"the International Neonatal Consortium (INC). Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates","volume":"81","author":"Ward","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1111\/jth.15141_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0091270009344986","article-title":"Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist","volume":"50","author":"Akers","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jth.15141_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2005-869525","article-title":"Preclinical and clinical studies with selective reversible direct P2Y12 antagonists","volume":"31","author":"Van Giezen","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.15141_bb0090","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1097\/PCC.0000000000002292","article-title":"Platelet inhibition with IV glycoprotein IIb\/IIIa Inhibitor to prevent thrombosis in pediatric patients undergoing aortopulmonary shunting","volume":"21","author":"Emani","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"10.1111\/jth.15141_bb0095","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15141_bb0100","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15141_bb0105","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic event","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15141_bb0110","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient\u2010level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jth.15141_bb0115","first-page":"465","article-title":"P2Y12 receptor function and response to cangrelor in neonates with cyanotic congenital heart disease","volume":"2","author":"Kaza","year":"2017","journal-title":"JACC BTS"},{"key":"10.1111\/jth.15141_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1039\/b919728a","article-title":"P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions","volume":"2","author":"Maloney","year":"2010","journal-title":"Integr Biol"},{"issue":"4","key":"10.1111\/jth.15141_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.12793\/tcp.2017.25.4.157","article-title":"Pharmacodynamic principles and the time course of immediate drug effects","volume":"25","author":"Holford","year":"2017","journal-title":"Transl Clin Pharmacol"},{"key":"10.1111\/jth.15141_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model\u2010based drug development\u2014part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1111\/jth.15141_bb0135","article-title":"Pharmacokinetic and pharmacodynamic data analysis: concepts and applications","volume":"74","author":"Gabrielsson","year":"2010","journal-title":"Am J Pharm Educ"},{"issue":"4","key":"10.1111\/jth.15141_bb0140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.107.715821","article-title":"Dosing of clopidogrel for platelet inhibition in infants and young children","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.15141_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet\u2010collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.15141_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15141_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Topol EJ; for the BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/jth.15141_bb0160","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.clinthera.2005.06.008","article-title":"Newborns and drug studies: the NICHD\/FDA newborn drug development initiative","volume":"27","author":"Giacoia","year":"2005","journal-title":"Clin Ther"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15141","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:30:20Z","timestamp":1761535820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622004494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1538783622004494"],"URL":"https:\/\/doi.org\/10.1111\/jth.15141","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cangrelor PK\/PD analysis in post\u2010operative neonatal cardiac patients at risk for thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}